Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05571189 · ClinicalTrials.gov registry record · NA

Home Rehabilitation After Acute Pulmonary Embolism

A NA study of Pulmonary Embolism, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05571189: Completed NA study of Pulmonary Embolism, sponsored by University of Rochester.

NCT05571189 is a NA study of Pulmonary Embolism that has completed, run by University of Rochester. The registered enrollment target is 32 participants, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05571189, a NA study of Pulmonary Embolism, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.

Primary Outcome

The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the vector magnitude count.

Conditions Studied

Interventions

  • BEHAVIORAL Daily Activity Text
  • BEHAVIORAL Control Text

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-12-19
Est. Completion 2025-09-24
Phase NA
University of Rochester

636 total trials

What the finished NCT05571189 record still lists

NCT05571189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Daily Activity Text is the first listed.

NCT05571189 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05571189 about?

NCT05571189 is a clinical study titled "Home Rehabilitation After Acute Pulmonary Embolism". The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or tex...

What is the current status of trial NCT05571189?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-12-19. Estimated completion is 2025-09-24.

What conditions does trial NCT05571189 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT05571189?

The interventions under investigation include: Daily Activity Text (BEHAVIORAL), Control Text (BEHAVIORAL).

Who is sponsoring clinical trial NCT05571189?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05571189 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05571189's enrollment target sits among peer trials

32 43rd of 48 higher than 6 of 48 other Pulmonary Embolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05571189, the US trial registry maintained by the National Library of Medicine. NCT05571189 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.